Plasmid DNA can be used across an extensive range of applications. Therefore, ensuring the supply is purified in the right way is crucial for every given situation. Analytik Jena‘s CyBio FeliX Liquid ...

Asimov has introduced a new manufacturing platform aimed at improving the scalability and consistency of AAV production for gene therapies.

Adeno-associated viruses (AAV) have emerged as pivotal delivery vehicles for gene therapy due to their overall safety (less immunogenic), efficiency (broad tropism), and long-term gene expression.

The non-viral transfection reagents market presents growth opportunities driven by the demand for cost-effective, low-immunogenicity alternatives to viral vectors, particularly for nucleic acid-based ...

Technologies used for cell and gene therapy development have come a long way but there are still important challenges associated with lentivirus manufacture. GMP plasmids account for a substantial ...

CONROE, Texas, May 13, 2025 /PRNewswire/ -- VGXI, Inc., a leading contract development and manufacturing organization (CDMO) specializing in plasmid DNA biopharmaceuticals, including for use in gene ...

Translational results bolster confidence as Phase III trial for IMNN-001 in advance epithelial ovarian cancer gets underway.

Organisms must adapt to ever-changing environments, otherwise they risk being outcompeted or eliminated. To do this, they have evolved methods for importing DNA from elsewhere and utilizing it for ...

IMNN-001, based on IMUNON’s proprietary TheraPlas technology platform, is an interleukin-12 DNA plasmid vector incorporated into a novel nanoparticle delivery system, enabling cell transfection ...